SEEK Flashcards
(117 cards)
Poor prognostic factors of HPS
lymphoma, age >30, higher ferritin elevation, marked thrombocytopenia, male sex, and low albumin
2ndary HLH causes
HIV
lymphoma
EBV
aka macrophage activation syndrome with JIA, SLE, adult Still’s dz
HLH diagnostic criteria
Testing for HLH includes
functional NKcell receptor activity
soluble CD25 testing
Ferritin
Treatment options for HLH
- Dex + Etop +/- cyclosporine A, doxorubicin, IVIG, ruxolitinib, anakinra, and allogeneic stem cell transplant.
- Cyclophosphamide, adriamycin, vincristine, prednisone (CHOP) and rituximab – in lymphoma and EBV
- PLEX
- Splenectomy (relapse)
Bradypnea
airway obstruction, COPD
“shark-fin” gradual rise in exhaled CO
vent dyssynchrony/double trigger
Inverse ratio I:E
- end inspiration with no CO2
- fast rise, mix of gas, emptying of alveoli
- Inspiration
Preferred therapy for WPW
Ibutilide
- Class III (K+) antiarrhythmic drug that prolongs refractoriness of both the AV node and accessory pathway and acutely terminates atrial fibrillation or flutter
Procainamide
- Class Ia (Na+) antiarrhythmic that increases refractoriness of atrial and ventricular myocardium without any AV nodal-blocking effect
3 Characteristics concerning for preexcitation (WPW) for afib w/ accessory pathway
wide complex tachyarrhythmia
irregularly irregular rhythm
varying widths of the QRS complexes
Why no Dig or Adenosine in WPW/pre-excitation rhythm
May precipitate ventricular arrhythmia (AV-node blockers)
*verapamil lengthens AV refractoriness without effect on accessory pathway
When/who to feed in the ICU
less than 60% protein intake by day 7-10
TTP - define, 2 types, and treatment
- reduced von Willebrand factor-cleaving protease ADAMTS13
- autoimmune (Ab) vs genetic mutation
- platelet-rich thrombi, thrombocytopenia (<30K), microangiopathic hemolytic anemia (<10), and organ damage (ARF, AMS, seizure)
- PLEX, glucocorticoids, and rituximab
Monoclonal Ab for refractory TTP
Caplacizumab, binds to von Willebrand factor & blocks its interaction with platelet glycoprotein 1b-IX-V
- HERCULES and TITAN studies demonstrated that the addition of caplacizumab to immunosuppression and plasma exchange in severe immune-mediated TTP led to fewer deaths, faster normalization of platelet count, fewer exacerbations, and shorter hospital stays
TXA mechanism
reversible and competitive manner on plasminogen, reducing the affinity of plasminogen to fibrin and resulting in reduced conversion of plasminogen to plasmin – prevent DIC
CRASH-2: 9% reduction in relative risk of mortality when tranexamic acid was administered within 3 h to patients with a systolic BP <75 mm Hg and significant hemorrhage or a risk of significant hemorrhage
MATTERs - good when used early, but no difference in 24-h mortality and higher rates of venous thrombotic events
Lung compliance
C = ΔV/ΔP
normal would be 70-100
Treatment of bacterial meningitis
vanco
ceftriaxone
amp if >50 yo or RF
- given dex 0.15mg/kg q6 hrs early, dc by day 4 if neg workup
causes N menin, S pneumo, L monocytoges
Check point inhibitor (anti-PD1, CTLA-4)
Presentation/side effects and treatment
- rash, colitis, pneumonitis, myocarditis, encephelitis, etc
Presentation: confusion, weakness, rotatory nystagmus, peripheral neuropathy - paraneoplastic syndrome, likely caused by anti-Ma2 antibodies against both central and peripheral neurons and associated with renal cell carcinoma
TX: steroids, PLEX
How does Dantrolene treat MH?
MOA: binds to ryanodine receptor type 1 (RYR-1) and inhibiting calcium ion release from the sarcoplasmic reticulum.
2.5 mg/kg, repeated every 5 min until reversal of the reaction or a total dose of 10 mg/kg is reached
Volume control
- trigger, target, cycle
trigger time
target flow
cycle volume
Pressure control
- trigger, target, cycle
trigger time
target insp pressure
cycle insp time
Clinical signs of botulism
GI: vomiting
Neuro: descending neuropathy/weakness
- CN III, CN IV (accommodative paresis, ptosis, ophthalmoparesis, and dilated pupils)
- bulbar CN 9-12 (dysarthria, dysphagia, and dysphonia)
- bilateral presentation